Search results for "Rheum"

showing 10 items of 1028 documents

Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-…

2019

Introduction There are some controversies about treatment modalities in osteoarthritis (OA), including chondroitin sulfate (CS). The objective of this study was to determine whether CS is effective at alleviating pain and improving function in patients with knee OA and to identify the factors that explain inconsistencies in clinical trial results. Methods We conducted a systematic review of randomized, placebo-controlled trials, searching the databases Medline, Cochrane central register for controlled trials and Scopus. Random effects meta-analysis was then performed, using tau2 and I2 statistics to assess heterogeneity. The pain and Lequesne index (LI) scores were expressed as standardized…

030213 general clinical medicinemedicine.medical_specialtyFunnel plotChondroitin sulfatePainReviewOsteoarthritisPlacebo03 medical and health sciences0302 clinical medicineRheumatologyInternal medicineOsteoarthritismedicineHumansMeta-analysiPharmacology (medical)Pain MeasurementRandomized Controlled Trials as TopicClinical Trials as Topicbusiness.industryChondroitin SulfatesFunctional statusGeneral MedicineOsteoarthritis KneeRandom effects modelmedicine.diseaseArthralgiaRheumatologyConfidence intervalFunctional statuClinical trialMeta-analysis030220 oncology & carcinogenesisMeta-analysisDietary SupplementsOsteoarthritibusinessAdvances in Therapy
researchProduct

2006

Prior studies demonstrate that adenosine, acting at one or more of its receptors, mediates the anti-inflammatory effects of methotrexate in animal models of both acute and chronic inflammation. Both adenosine A2A and A3 receptors contribute to the anti-inflammatory effects of methotrexate treatment in the air pouch model of inflammation, and the regulation of inflammation by these two receptors differs at the cellular level. Because different factors may regulate inflammation at different sites we examined the effect of low-dose weekly methotrexate treatment (0.75 mg/kg/week) in a model of acute peritoneal inflammation in adenosine A2A receptor knockout mice and A3 receptor knockout mice an…

0303 health sciencesmedicine.medical_specialtybusiness.industryImmunologyAdenosine A2A receptorInflammationAdenosine A3 receptorAdenosine3. Good health03 medical and health sciencesInterleukin 100302 clinical medicineEndocrinologyRheumatologyInternal medicineKnockout mousemedicineImmunology and AllergyTumor necrosis factor alphamedicine.symptombusinessReceptor030304 developmental biology030215 immunologymedicine.drugArthritis Research & Therapy
researchProduct

Anakinra for severe forms of COVID-19

2020

2019-20 coronavirus outbreakAnakinraRheumatologyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyImmunology and AllergyMedicinebusinessVirologyArticlemedicine.drugThe Lancet Rheumatology
researchProduct

The COVID-19 outbreak and rheumatologic skin diseases.

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryClinical Laboratory TechniquesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEOutbreakCOVID-19DermatologyGeneral MedicineVirologySkin DiseasesDisease OutbreaksArthritis RheumatoidCOVID-19 TestingRisk FactorsMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry

2021

OBJECTIVES: The study aimed to characterise the Polish population of (ANCA)-associated vasculitides (AAV) with respiratory involvement (RI), in comparison to the subgroup without lung manifestations and the other cohorts. METHODS: Retrospective analysis of the Polish population of AAV with RI was conducted, based on data from the POLVAS registry. Standard descriptive statistics, χ2 test, and Mann-Whitney U test were used to perform comparisons. RESULTS: Among 461 cases qualified to this study, there were 316 cases with RI (68.5%), 206 with granulomatosis with polyangiitis (GPA) (65.2%), 80 with eosinophilic granulomatosis with polyangiitis (EGPA) (25.3%) and 30 with microscopic polyangiitis…

ANCAImmunologyGranulomatosis with PolyangiitisMicroscopic PolyangiitisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAAVChurg-Strauss SyndromevasculitisAntibodies Antineutrophil Cytoplasmiclung involvementRheumatologyRecurrenceHumansImmunology and AllergyRegistriesRetrospective Studiesrespiratory involvementClinical and Experimental Rheumatology
researchProduct

Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders.

2001

The topical anti-inflammatory activity of extracts from Cassia angustifolia, Rheum palmatum, Coptis chinensis, Phellodendron amurense and Scutellaria baicalensis, plants used in traditional East Asian medicine against different skin disorders, was studied. Though in different degree, all the extracts significantly inhibited the edema induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), in both single or multiple application, oxazolone, and arachidonic acid (AA). None of the extracts inhibited in vitro the activity of phospholipase A(2) (PLA(2)) from Naja naja.

Administration TopicalAnti-Inflammatory AgentsPharmacognosyCassia angustifoliaPhospholipases Alaw.inventionMicelawCassiaDrug DiscoveryMedicineAnimalsEdemaRosalesPharmacologyRheum palmatumPlants MedicinalTraditional medicinebiologybusiness.industryOxazoloneGeneral MedicineCoptis chinensisbiology.organism_classificationPolygonaceaePhellodendron amurenseScutellaria baicalensisFemalebusinessPhytotherapyDrugs Chinese HerbalFitoterapia
researchProduct

Dermatomyositis induced by the secretion of Phyllomedusa bicolor or Kambô frog - A case report

2020

The Amazonian Kambô frog, Phyllomedusa bicolor, is commonly known for the potential benefits of its secretion. The Kambô ritual consists in applying the toxin directly to a freshly burnt skin area, since it is believed by natives and shamans to purify and strengthen the body and mind of the user. We describe a 33-year old female with a history of periodic use of Kambô toxin who presented with a 3-week course of asthenia, malaise, myalgia, and proximal muscle weakness predominantly in the lower limbs. She had elevated muscle enzymes and an abnormal electromyography. We used the 2017 European League Against Rheumatism and American College of Rheumatology classification criteria to establish t…

Adult0106 biological sciencesmyalgiamedicine.medical_specialtyProximal muscle weaknessRanidaePhyllomedusa bicolorToxicology01 natural sciencesDermatomyositisMalaise03 medical and health sciencesPrednisoneInternal medicineAnimalsHumansMedicine0303 health sciencesbiologybusiness.industry010604 marine biology & hydrobiology030302 biochemistry & molecular biologyDermatomyositismedicine.diseasebiology.organism_classificationDermatologyRheumatologyFemalemedicine.symptombusinessRheumatismmedicine.drugToxicon
researchProduct

Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis

2015

AbstractRheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy.In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and mon…

Adult0301 basic medicinerheumatoid arthritismedicine.medical_specialtyMagnetic Resonance SpectroscopyClinical BiochemistryPopulationPharmaceutical ScienceDiseaseCreatineGastroenterologyAnalytical ChemistryArthritis Rheumatoid03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMetabolomicsValineInternal medicineDrug DiscoverymedicineHumanseducation1H NMR spectroscopySpectroscopyAged030203 arthritis & rheumatologyeducation.field_of_studyCreatinineMiddle Agedmedicine.diseasemetabolomics030104 developmental biologychemistryRheumatoid arthritisDisease ProgressionFemaleProtonsLeucineBiomarkersJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Prolidase deficiency in two dermatological patients in western Sicily

2020

Prolidase deficiency is a rare disorder inherited through an autosomal recessive gene. The hallmark of the disorder are iminodipeptiduria, chronic skin ulcers, recurring infections, mental retardation and characteristic facial appearance, although prolidase deficiency can occur with no clinical manifestation. The primary biological function of the enzyme involves the metabolism of collagen degradation products and the recycling of proline for collagen resynthesis. We describe two patients with prolidase deficiency and review the different clinical manifestations suggesting the pathogenetic mechanism through few hypotheses.

Adult030203 arthritis & rheumatologyProlidase deficiencyCollagen degradationbusiness.industryDermatologyClinical manifestationmedicine.disease030207 dermatology & venereal diseases03 medical and health sciencesFacial appearanceChronic skin ulcers0302 clinical medicineImmunologymedicineHumansFemaleProlidase deficiency ulcersProlidase DeficiencyIminodipeptiduriabusinessSicilyGiornale Italiano di Dermatologia e Venereologia
researchProduct

Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation an…

2010

Introduction: Infliximab is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-α) that has been introduced recently for Behcet's disease (BD) patients who were resistant to standard treatment. The aim of this study was to analyse the functional changes of Vγ9/Vδ2 T lymphocytes in both active and inactive disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity. Methods: We investigated 1) cell expansion, 2) expression of TNFRII receptor, 3) perforin and gamma interferon (IFN) content, 4) release of granzyme A (GrA) and 5) phenotype changes, in vitro and in vivo, in Vγ9/Vδ2 T lymphocytes by means of fluorescence-activated cell sorter …

AdultAdolescentCell SurvivalT cellLymphocyteT-LymphocytesImmunologyGranzymesInterferon-gammaYoung AdultRheumatologyAntigenmedicineImmunology and AllergyHumansReceptors Tumor Necrosis Factor Type IIInterferon gammaCells CulturedAgedCell ProliferationbiologyPerforinBehcet SyndromeAntibodies MonoclonalReceptors Antigen T-Cell gamma-deltaMiddle AgedInfliximabmedicine.anatomical_structurePhenotypeGranzymePerforinAntirheumatic AgentsCase-Control StudiesImmunologybiology.proteinGranzyme ATumor necrosis factor alphaFemalemedicine.drugResearch ArticleArthritis Research & Therapy
researchProduct